Methods of treatment using ranolazine and related piperazine derivatives
US5506229A · kind A · utility
34Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 1992 |
| Grant date | Apr 9, 1996 |
| Priority date | — |
| Expiry date | Oct 1, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Piperazine derivatives, particularly ranolazine, are useful for treatment of tissues experiencing a physical or chemical insult, and specifically for treating cardioplegia, hypoxic and/or reperfusion injury to cardiac or skeletal muscle or brain tissue, and for use in transplants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.